Elevate Uranium Ltd
Elevate Uranium Ltd (EL8.AX) Financial Performance & Income Statement Overview
Review Elevate Uranium Ltd (EL8.AX) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Elevate Uranium Ltd (EL8.AX) Income Statement & Financial Overview
Review Elevate Uranium Ltd EL8.AX income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $62916.00 | $58759.00 | $0.00 | $47470.00 |
| Gross Profit | -$62916.00 | -$58759.00 | $0.00 | -$47470.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $5.90M | $2233.00 | $2233.00 | $3.43M |
| Operating Expenses | $5.90M | $2294.00 | $2294.00 | $3.43M |
| Total Costs & Expenses | $5.96M | $2294.00 | $2294.00 | $3.48M |
| Interest Income | $314261.00 | $161986.00 | $79.00 | $169589.00 |
| Interest Expense | $3673.00 | $4498.00 | $0.00 | $4478.00 |
| Depreciation & Amortization | $62916.00 | $29.00 | $29.00 | $47470.00 |
| EBITDA | -$6.26M | -$2233.00 | -$2233.00 | -$3.73M |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | -$5.96M | -$2263.00 | -$2263.00 | -$3.48M |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Other Income/Expenses (Net) | -$359540.00 | $47851.00 | $48.00 | -$309222.00 |
| Income Before Tax | -$6.32M | -$2215.00 | -$2215.00 | -$3.79M |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| Income Tax Expense | -$355867.00 | $1.00 | $0.00 | $0.00 |
| Net Income | -$6.32M | -$2215.00 | -$2215.00 | -$3.79M |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | $0.00 |
| EPS | -$0.02 | -$0.008 | -$0.008 | -$0.01 |
| Diluted EPS | -$0.02 | -$0.008 | -$0.008 | -$0.01 |
| Weighted Avg Shares Outstanding | $308.45M | $280.36M | $280.36M | $275.57M |
| Weighted Avg Shares Outstanding (Diluted) | $308.45M | $280.36M | $280.36M | $275.57M |
The company's financials show resilient growth, with revenue advancing from $0.00 in Q4 2023 to $0.00 in Q4 2024. Gross profit remained healthy with margins at N/A in Q4 2024 compared to N/A in Q4 2023. Operating income hit -$5.96M last quarter, sustaining a consistent N/A margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at -$6.26M. Net income dropped to -$6.32M, while earnings per share reached -$0.02. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan